🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/09/2026 68,85 72,37 68,08 71,86 +4,46% 6,22% 3.115.700
21/09/2026 67,46 69,26 66,06 68,79 +3,47% 4,74% 2.347.400
18/09/2026 67,83 68,05 66,36 66,48 -1,86% 2,49% 4.016.000
17/09/2026 68,91 68,91 67,00 67,74 +2,96% 2,78% 3.210.100
16/09/2026 70,41 71,93 64,50 65,79 -6,91% 10,55% 5.111.900
15/09/2026 82,89 83,55 70,61 70,67 -12,40% 15,62% 4.369.900
14/09/2026 82,98 83,27 79,93 80,67 -2,63% 4,03% 1.329.200
11/09/2026 83,75 85,98 82,36 82,85 +0,11% 4,33% 1.335.800
10/09/2026 81,58 83,38 80,33 82,76 +0,16% 3,74% 1.020.300
09/09/2026 84,65 87,20 82,16 82,63 -2,91% 5,95% 3.668.200
08/09/2026 84,22 86,96 83,54 85,11 -1,42% 4,06% 1.567.700
04/09/2026 85,87 86,96 84,20 86,34 -0,17% 3,21% 757.600
03/09/2026 85,18 86,79 83,46 86,49 +1,31% 3,91% 1.370.500
02/09/2026 82,87 85,47 82,09 85,37 +3,18% 4,08% 1.525.400
01/09/2026 81,14 83,27 80,76 82,74 +0,42% 3,09% 1.330.600
31/08/2026 83,13 83,76 80,75 82,39 -2,97% 3,61% 1.595.500
28/08/2026 87,99 88,25 84,20 84,91 -4,15% 4,60% 1.282.200
27/08/2026 89,59 89,59 88,06 88,59 -0,59% 1,71% 857.500
26/08/2026 88,45 89,83 86,80 89,12 +0,27% 3,42% 859.500
25/08/2026 88,00 90,21 87,00 88,88 +2,48% 3,65% 983.000
24/08/2026 86,77 87,01 85,50 86,73 -0,44% 1,74% 1.104.400
21/08/2026 87,90 88,46 85,94 87,11 -0,41% 2,87% 1.089.800
20/08/2026 88,23 88,45 85,90 87,47 -2,17% 2,89% 896.800
19/08/2026 89,51 90,00 87,58 89,41 +1,72% 2,70% 1.363.400
18/08/2026 87,72 88,35 85,98 87,90 -0,90% 2,70% 975.000
17/08/2026 86,44 88,94 86,26 88,70 +2,38% 3,10% 929.700
14/08/2026 84,75 87,17 83,78 86,64 +1,23% 4,00% 818.000
13/08/2026 87,60 88,06 84,76 85,59 -1,90% 3,76% 1.101.900
12/08/2026 89,09 90,61 87,16 87,25 -2,23% 3,87% 1.119.600
11/08/2026 88,94 90,97 88,45 89,24 +1,03% 2,83% 1.042.500